Form 8-K - Current report:
SEC Accession No. 0001193125-25-121801
Filing Date
2025-05-16
Accepted
2025-05-16 17:11:00
Documents
14
Period of Report
2025-05-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d918670d8k.htm   iXBRL 8-K 44348
2 EX-10.1 d918670dex101.htm EX-10.1 143436
  Complete submission text file 0001193125-25-121801.txt   349720

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA medp-20250516.xsd EX-101.SCH 2838
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE medp-20250516_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE medp-20250516_pre.xml EX-101.PRE 10804
16 EXTRACTED XBRL INSTANCE DOCUMENT d918670d8k_htm.xml XML 3487
Mailing Address 5375 MEDPACE WAY CINCINNATI OH 45227
Business Address 5375 MEDPACE WAY CINCINNATI OH 45227 (513) 579-9911
Medpace Holdings, Inc. (Filer) CIK: 0001668397 (see all company filings)

EIN.: 320434904 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37856 | Film No.: 25960469
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)